These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 16540035

  • 21. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T, Saruta T, Rakugi H, Fujimoto A, Ueshima K, Yasuno S, Oba K, Takeda K, Higaki J, Nakao K, CASE-J trial Group.
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [Abstract] [Full Text] [Related]

  • 22. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [Abstract] [Full Text] [Related]

  • 23. Electrocardiographic left ventricular hypertrophy criteria and ambulatory blood pressure monitoring parameters in adults.
    Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Fernandez-Alonso C, Martinez Vizcaino V, Cantera CM, Guenaga-Saenz N, González-Viejo N, García-Ortiz L, EVIDENT Study, Spain.
    Am J Hypertens; 2014 Mar; 27(3):355-62. PubMed ID: 24190901
    [Abstract] [Full Text] [Related]

  • 24. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C.
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [Abstract] [Full Text] [Related]

  • 25. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt JH, Kopyt N, Levey AS, Nwachuku C, Pressel S, Reisin E, Walworth C, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.
    Arch Intern Med; 2004 May 10; 164(9):969-76. PubMed ID: 15136305
    [Abstract] [Full Text] [Related]

  • 26. [Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai].
    Zhan S, Liu M, Yao W, Hu Y, Li L, Zhu G, Sun N, Dai L.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Jun 10; 23(3):182-5. PubMed ID: 12411085
    [Abstract] [Full Text] [Related]

  • 27. [Blood pressure findings in Spanish dyslipidemic primary-care patients. LIPICAP-PA Study].
    Rodríguez-Roca GC, Alonso-Moreno FJ, Barrios V, Llisterri JL, Lou S, Matalí A, Banegas JR, Grupo de Trabajo de Riesgo Cardiovascular, Grupo de Hipertensión Arterial de la Sociedad Española.
    Rev Esp Cardiol; 2007 Aug 10; 60(8):825-32. PubMed ID: 17688851
    [Abstract] [Full Text] [Related]

  • 28. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun 10; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 29. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O, Inal V, Baysan O, Sağlam K.
    Anadolu Kardiyol Derg; 2008 Oct 10; 8(5):342-6. PubMed ID: 18849224
    [Abstract] [Full Text] [Related]

  • 30. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study.
    Niiranen TJ, Jula AM, Kantola IM, Karanko H, Reunanen A.
    J Hum Hypertens; 2007 Oct 10; 21(10):788-94. PubMed ID: 17637793
    [Abstract] [Full Text] [Related]

  • 31. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment--a national study in Sweden.
    Journath G, Nilsson PM, Petersson U, Paradis BA, Theobald H, Erhardt L.
    Blood Press; 2005 Oct 10; 14(3):144-50. PubMed ID: 16036494
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review.
    Cuspidi C, Rescaldani M, Sala C, Negri F, Grassi G, Mancia G.
    J Hypertens; 2012 Nov 10; 30(11):2066-73. PubMed ID: 22914541
    [Abstract] [Full Text] [Related]

  • 33. [Cardiovascular disease epidemiology and risk factors in primary care].
    Baena Díez JM, del Val García JL, Tomàs Pelegrina J, Martínez Martínez JL, Martín Peñacoba R, González Tejón I, Raidó Quintana EM, Pomares Sajkiewicz M, Altés Boronat A, Alvarez Pérez B, Piñol Forcadell P, Rovira España M, Oller Colom M.
    Rev Esp Cardiol; 2005 Apr 10; 58(4):367-73. PubMed ID: 15847733
    [Abstract] [Full Text] [Related]

  • 34. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB.
    J Hum Hypertens; 2007 Aug 10; 21(8):625-32. PubMed ID: 17476291
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study.
    Félix-Redondo FJ, Fernández-Bergés D, Calderón A, Consuegra-Sánchez L, Lozano L, Barrios V.
    J Hypertens; 2012 Jul 10; 30(7):1460-7. PubMed ID: 22573128
    [Abstract] [Full Text] [Related]

  • 36. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May 10; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 37. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 May 10; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 38. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
    da Costa W, Riera AR, Costa Fde A, Bombig MT, de Paola AA, Carvalho AC, Fonseca FH, Luna Filho B, Póvoa R.
    J Electrocardiol; 2008 May 10; 41(6):724-9. PubMed ID: 18954613
    [Abstract] [Full Text] [Related]

  • 39. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P, Majkowska L, Kaliszczak R, Safranow K, Adler G, Goracy I.
    Kardiol Pol; 2006 Sep 10; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [Abstract] [Full Text] [Related]

  • 40. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Sep 10; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.